D'Huyvetter M - Search Results

1

Theranostics in immuno-oncology using nanobody derivatives.

Lecocq Q, De Vlaeminck Y, Hanssens H, D'Huyvetter M, Raes G, Goyvaerts C, Keyaerts M, Devoogdt N, Breckpot K. Lecocq Q, et al. Theranostics. 2019 Oct 15;9(25):7772-7791. doi: 10.7150/thno.34941. eCollection 2019. Theranostics. 2019. PMID: 31695800 Free PMC article. Review.

2

Immuno-imaging using nanobodies.

Vaneycken I, D'huyvetter M, Hernot S, De Vos J, Xavier C, Devoogdt N, Caveliers V, Lahoutte T. Vaneycken I, et al. Curr Opin Biotechnol. 2011 Dec;22(6):877-81. doi: 10.1016/j.copbio.2011.06.009. Epub 2011 Jul 2. Curr Opin Biotechnol. 2011. PMID: 21726996 Review.

3

Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.

D'Huyvetter M, Aerts A, Xavier C, Vaneycken I, Devoogdt N, Gijs M, Impens N, Baatout S, Ponsard B, Muyldermans S, Caveliers V, Lahoutte T. D'Huyvetter M, et al. Contrast Media Mol Imaging. 2012 Mar-Apr;7(2):254-64. doi: 10.1002/cmmi.491. Contrast Media Mol Imaging. 2012. PMID: 22434639 Free article.

4

Site-specific labeling of his-tagged Nanobodies with ⁹⁹mTc: a practical guide.

Xavier C, Devoogdt N, Hernot S, Vaneycken I, D'Huyvetter M, De Vos J, Massa S, Lahoutte T, Caveliers V. Xavier C, et al. Methods Mol Biol. 2012;911:485-90. doi: 10.1007/978-1-61779-968-6_30. Methods Mol Biol. 2012. PMID: 22886271

5

Molecular imaging using Nanobodies: a case study.

Devoogdt N, Xavier C, Hernot S, Vaneycken I, D'Huyvetter M, De Vos J, Massa S, De Baetselier P, Caveliers V, Lahoutte T. Devoogdt N, et al. Methods Mol Biol. 2012;911:559-67. doi: 10.1007/978-1-61779-968-6_35. Methods Mol Biol. 2012. PMID: 22886276

6

SPECT imaging of joint inflammation with Nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis.

Put S, Schoonooghe S, Devoogdt N, Schurgers E, Avau A, Mitera T, D'Huyvetter M, De Baetselier P, Raes G, Lahoutte T, Matthys P. Put S, et al. J Nucl Med. 2013 May;54(5):807-14. doi: 10.2967/jnumed.112.111781. Epub 2013 Feb 27. J Nucl Med. 2013. PMID: 23447654 Free article.

7

Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.

Xavier C, Vaneycken I, D'huyvetter M, Heemskerk J, Keyaerts M, Vincke C, Devoogdt N, Muyldermans S, Lahoutte T, Caveliers V. Xavier C, et al. J Nucl Med. 2013 May;54(5):776-84. doi: 10.2967/jnumed.112.111021. Epub 2013 Mar 13. J Nucl Med. 2013. PMID: 23487015 Free article.

8

Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies.

Lemaire M, D'Huyvetter M, Lahoutte T, Van Valckenborgh E, Menu E, De Bruyne E, Kronenberger P, Wernery U, Muyldermans S, Devoogdt N, Vanderkerken K. Lemaire M, et al. Leukemia. 2014 Feb;28(2):444-7. doi: 10.1038/leu.2013.292. Epub 2013 Oct 9. Leukemia. 2014. PMID: 24166214 No abstract available.

9

Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.

Evazalipour M, D'Huyvetter M, Tehrani BS, Abolhassani M, Omidfar K, Abdoli S, Arezumand R, Morovvati H, Lahoutte T, Muyldermans S, Devoogdt N. Evazalipour M, et al. Contrast Media Mol Imaging. 2014 May-Jun;9(3):211-20. doi: 10.1002/cmmi.1558. Contrast Media Mol Imaging. 2014. PMID: 24700748 Free article.

10

Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody.

D'Huyvetter M, Vincke C, Xavier C, Aerts A, Impens N, Baatout S, De Raeve H, Muyldermans S, Caveliers V, Devoogdt N, Lahoutte T. D'Huyvetter M, et al. Theranostics. 2014 Apr 25;4(7):708-20. doi: 10.7150/thno.8156. eCollection 2014. Theranostics. 2014. PMID: 24883121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page